🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: To assess, in the same study, the safety of sarilumab a...
Status
Completed
Location
Investigational Site Number 840152
Start Date
2013-03
Trial ID
NCT01768572
The aim of this clinical trial is to determine whether nicorandil works in ...
Status
Not Yet Recruiting
Location
Ain Shams University
Start Date
2026-08
Trial ID
NCT07730723
Treatments Being Tested
The purpose of the study is to better understand the factors present in the...
Status
Completed
Location
Outpatient Care Center
Start Date
2015-08
Trial ID
NCT02451748
The purpose of this study is to assess the efficacy and safety of tocilizum...
Status
Completed
Location
Seoul National Univ. Hospital
Start Date
2009-10
Trial ID
NCT01211834
Treatments Being Tested
This study is designed to evaluate the effectiveness of adding etanercept t...
Status
Completed
Location
Research Site
Start Date
2011-03
Trial ID
NCT01313208
Treatments Being Tested
Approximately, 40 to 50% of patients with rheumatoid arthritis (RA), the mo...
Status
Recruiting
Location
Hôpitaux Universitaires de Strasbourg
Start Date
2016-03-30
Trial ID
NCT02714634
To assess comparative radiographic efficacy, clinical efficacy and safety o...
Status
Terminated
Location
Multiple Locations
Start Date
2008-09
Trial ID
NCT00706797
Treatments Being Tested
This single-arm study evaluated the long-term efficacy and safety of tocili...
Status
Completed
Location
Multiple Locations
Start Date
2005-09
Trial ID
NCT00720798
The study has been designed as a 48-week, double-blind, randomized, control...
Status
Completed
Location
University of Nebraska Medical Center
Start Date
2001-03-27
Trial ID
NCT00579878
Primary Objective: To assess the effect of sarilumab in combination with c...
Status
Completed
Location
Investigational Site Number 250007
Start Date
2018-03-05
Trial ID
NCT03449758
Treatments Being Tested